Curtis Jeptha P, Geary Lori L, Wang Yongfei, Chen Jersey, Drye Elizabeth E, Grosso Laura M, Spertus John A, Rumsfeld John S, Weintraub William S, Masoudi Frederick A, Brindis Ralph G, Krumholz Harlan M
Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):628-37. doi: 10.1161/CIRCOUTCOMES.111.964569. Epub 2012 Sep 4.
Variation in outcomes after percutaneous coronary interventions (PCI) may reflect differences in quality of care. To date, however, we lack a methodology to monitor and improve national hospital 30-day mortality rates among patients undergoing PCI.
We developed hierarchical logistic regression models to calculate hospital risk-standardized 30-day all-cause PCI mortality rates. Due to differences in risk, patients were divided into 2 cohorts: those with ST-segment elevation myocardial infarction or cardiogenic shock, and those with no ST-segment elevation myocardial infarction and no cardiogenic shock. The models were derived using 2006 data from the CathPCI Registry linked with administrative claims data, and validated using comparable 2005 data. In the derivation cohort of the ST-segment elevation myocardial infarction or shock model (n=15 123), the unadjusted 30-day mortality rate was 9.2%. The final model included 13 variables with the observed mortality rates ranging from 1.4% to 40.3% across deciles of the predicted patient mortality rates. The 25th and 75th percentiles of the risk-standardized mortality rate were 8.5% and 9.7%, with 5th and 95th percentiles of 7.6% and 11.0%. In the derivation cohort of the no ST-segment elevation myocardial infarction and no shock model (n=110 529), the unadjusted 30-day mortality rate was 1.4%. The final model included 16 variables with the observed predicted mortality rates ranging from 0.1% to 7.0% across deciles of the predicted patient mortality rates. The 25th and 75th percentiles of the risk-standardized mortality rate across 612 hospitals were 1.3% and 1.6%, with 5th and 95th percentiles of 1.0% and 2.0%.
These National Quality Forum endorsed registry-based models produce estimates of hospital risk-standardized mortality rates for patients undergoing PCI.
经皮冠状动脉介入治疗(PCI)后结果的差异可能反映了医疗质量的不同。然而,迄今为止,我们缺乏一种方法来监测和改善全国范围内接受PCI治疗患者的30天医院死亡率。
我们开发了分层逻辑回归模型来计算医院风险标准化的30天全因PCI死亡率。由于风险不同,患者被分为两个队列:ST段抬高型心肌梗死或心源性休克患者,以及无ST段抬高型心肌梗死且无心源性休克患者。这些模型使用2006年来自心脏PCI注册中心的数据与行政索赔数据相结合得出,并使用2005年的可比数据进行验证。在ST段抬高型心肌梗死或休克模型的推导队列(n = 15123)中,未经调整的30天死亡率为9.2%。最终模型包括13个变量,在预测患者死亡率的十分位数中,观察到的死亡率范围为1.4%至40.3%。风险标准化死亡率的第25百分位数和第75百分位数分别为8.5%和9.7%,第5百分位数和第95百分位数分别为7.6%和11.0%。在无ST段抬高型心肌梗死且无休克模型的推导队列(n = 110529)中,未经调整的30天死亡率为1.4%。最终模型包括16个变量,在预测患者死亡率的十分位数中,观察到的预测死亡率范围为0.1%至7.0%。612家医院的风险标准化死亡率的第25百分位数和第75百分位数分别为1.3%和1.6%,第5百分位数和第95百分位数分别为1.0%和2.0%。
这些经国家质量论坛认可的基于注册中心的模型可得出接受PCI治疗患者的医院风险标准化死亡率估计值。